Literature DB >> 29198043

The diagnosis of dementias: a practical tool not to miss rare causes.

Camilla Ferrari1, Benedetta Nacmias2, Sandro Sorbi3,2.   

Abstract

Dementia represents one of the most diffuse disorders of our Era. Alzheimer's disease is the principle cause of dementia worldwide. Metabolic, infectious, autoimmune, inflammatory, and genetic dementias represent a not negligible number of disorders, with increasing numbers in younger subjects. Due to the heterogeneity of patients and disorders, the diagnosis of dementia is challenging. In the present article, we propose a practical diagnostic approach following the two-step investigation procedure. The first step includes basic blood tests and brain neuroimaging, performed on all patients. After this first-line investigation, it is then possible to rule out metabolic causes of dementia and to identify three main subgroups in dementia: predominant gray matter atrophy, white matter disease, basal ganglia pathologies. The predominant gray matter atrophy subgroup includes neurodegenerative causes of dementia and some lysosomal storage disorders. The white matter subgroup indicates a comprehensive list of vascular dementia causes, mitochondrial diseases, and leukodystrophies. Whereas, the basal ganglia alterations are due to metal accumulation pathologies, such as iron, copper, or calcium. Each category has specific clinical hallmarks, accurately reported in the article, and requires specific second-line investigation. Thus, we indicate the distinct second diagnostic step of each disease. The proposed diagnostic flow-chart follows the clinical reasoning and helps clinicians through the differential diagnosis of dementia.

Entities:  

Keywords:  Dementia; Differential diagnosis; Practical tool; Rare dementia; Uncommon dementia

Mesh:

Year:  2017        PMID: 29198043     DOI: 10.1007/s10072-017-3206-0

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  73 in total

Review 1.  Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases.

Authors:  Michael G Erkkinen; Mee-Ohk Kim; Michael D Geschwind
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-04-02       Impact factor: 10.005

2.  Late-onset Tay-Sachs disease: phenotypic characterization and genotypic correlations in 21 affected patients.

Authors:  Orit Neudorfer; Gregory M Pastores; Bai J Zeng; John Gianutsos; Charles M Zaroff; Edwin H Kolodny
Journal:  Genet Med       Date:  2005-02       Impact factor: 8.822

3.  Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study.

Authors:  Maarten J Titulaer; Lindsey McCracken; Iñigo Gabilondo; Thaís Armangué; Carol Glaser; Takahiro Iizuka; Lawrence S Honig; Susanne M Benseler; Izumi Kawachi; Eugenia Martinez-Hernandez; Esther Aguilar; Núria Gresa-Arribas; Nicole Ryan-Florance; Abiguei Torrents; Albert Saiz; Myrna R Rosenfeld; Rita Balice-Gordon; Francesc Graus; Josep Dalmau
Journal:  Lancet Neurol       Date:  2013-01-03       Impact factor: 44.182

4.  MELAS: a nationwide prospective cohort study of 96 patients in Japan.

Authors:  Shuichi Yatsuga; Nataliya Povalko; Junko Nishioka; Koju Katayama; Noriko Kakimoto; Toyojiro Matsuishi; Tatsuyuki Kakuma; Yasutoshi Koga
Journal:  Biochim Biophys Acta       Date:  2011-04-02

5.  The novel PSEN1 M84V mutation associated to frontal dysexecutive syndrome, spastic paraparesis, and cerebellar atrophy in a dominant Alzheimer's disease family.

Authors:  Maura Gallo; Francesca Frangipane; Chiara Cupidi; Matteo De Bartolo; Sabina Turone; Camilla Ferrari; Benedetta Nacmias; Giuliana Grimaldi; Valentina Laganà; Rosanna Colao; Livia Bernardi; Maria Anfossi; Maria Elena Conidi; Franca Vasso; Sabrina Anna Maria Curcio; Maria Mirabelli; Nicoletta Smirne; Giusi Torchia; Maria Gabriella Muraca; Gianfranco Puccio; Raffaele Di Lorenzo; Maristella Piccininni; Andrea Tedde; Raffaele Giovanni Maletta; Sandro Sorbi; Amalia Cecilia Bruni
Journal:  Neurobiol Aging       Date:  2017-04-27       Impact factor: 4.673

6.  The behavioural/dysexecutive variant of Alzheimer's disease: clinical, neuroimaging and pathological features.

Authors:  Rik Ossenkoppele; Yolande A L Pijnenburg; David C Perry; Brendan I Cohn-Sheehy; Nienke M E Scheltens; Jacob W Vogel; Joel H Kramer; Annelies E van der Vlies; Renaud La Joie; Howard J Rosen; Wiesje M van der Flier; Lea T Grinberg; Annemieke J Rozemuller; Eric J Huang; Bart N M van Berckel; Bruce L Miller; Frederik Barkhof; William J Jagust; Philip Scheltens; William W Seeley; Gil D Rabinovici
Journal:  Brain       Date:  2015-07-02       Impact factor: 13.501

7.  EFNS guidelines for the diagnosis and management of Alzheimer's disease.

Authors:  J Hort; J T O'Brien; G Gainotti; T Pirttila; B O Popescu; I Rektorova; S Sorbi; P Scheltens
Journal:  Eur J Neurol       Date:  2010-10       Impact factor: 6.089

8.  Late onset of Huntington's disease.

Authors:  R H Myers; D S Sax; M Schoenfeld; E D Bird; P A Wolf; J P Vonsattel; R F White; J B Martin
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-06       Impact factor: 10.154

9.  Cognitive phenotypes in Alzheimer's disease and genetic risk.

Authors:  Julie S Snowden; Cheryl L Stopford; Camille L Julien; Jennifer C Thompson; Yvonne Davidson; Linda Gibbons; Antonia Pritchard; Corinne L Lendon; Anna M Richardson; Anoop Varma; David Neary; David Mann
Journal:  Cortex       Date:  2007-10       Impact factor: 4.027

Review 10.  Diagnostic accuracy of (18)F amyloid PET tracers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis.

Authors:  Elizabeth Morris; Anastasia Chalkidou; Alexander Hammers; Janet Peacock; Jennifer Summers; Stephen Keevil
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-11-28       Impact factor: 9.236

View more
  2 in total

Review 1.  Topographical disorientation in aging. Familiarity with the environment does matter.

Authors:  Antonella Lopez; Alessandro O Caffò; Andrea Bosco
Journal:  Neurol Sci       Date:  2018-06-12       Impact factor: 3.307

2.  Survival, effect measures, and impact numbers after dementia diagnosis: a matched cohort study.

Authors:  Josep Garre-Olmo; Anna Ponjoan; José Maria Inoriza; Jordi Blanch; Inma Sánchez-Pérez; Rafel Cubí; Rosa de Eugenio; Oriol Turró-Garriga; Joan Vilalta-Franch
Journal:  Clin Epidemiol       Date:  2019-07-16       Impact factor: 4.790

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.